Allergy/Imm Medical News about Towne cytomegalovirus vaccine

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Novel therapies for children with severe asthma

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Safety and immunogenicity of Towne cytomegalovirus vaccine with or without adjuvant recombinant interleukin-12
Vaccine , 08/23/06

Mark A. Jacobson, et al. - The Towne, human cytomegalovirus (CMV) vaccine is safe and immunogenic but has not prevented infection at doses tested to date...Thus, adjuvant IL-12 may be a promising strategy for improving antibody and T cell immune responses to a CMV vaccine

<< Previous
Proteomic analysis of Neisseria lactamica and N eisseria...

Next >>
Comparison of thiomersal-free and thiomersal-containing...

CDC Survey Shows Gains in Overall Adolescent Vaccination Rates for 2008. But Majority Still Lack Immunizations for Tdap, MCV4
American Family Physician, 10/23/09 Relevance Score: 49%%

A survey of adolescent experiences of human papillomavirus vaccination in the Manchester study
British Journal of Cancer, 10/09/09 Relevance Score: 49%%

H1N1 Vaccine Deliveries Begin. Early Doses to Arrive This Week
American Family Physician, 10/07/09 Relevance Score: 48%%

Human Papillomavirus Vaccine Uptake, Predictors of Vaccination, and Self-Reported Barriers to Vaccination
Journal of Women's Health, 10/05/09 Relevance Score: 48%%

One Dose of H1N1 Vaccine Immunogenic in High Percentage of Youth Ages 10 to 17. Younger Children Likely Will Need Two Doses
American Family Physician, 10/05/09 Relevance Score: 48%%